Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement

Medicine and Dentistry

• ACE Inhibitor 50%
• Adrenergic Receptor 50%
• Adrenergic Receptor Blocking Agent 100%
• Anesthesiology 50%
• Angiotensin 50%
• Angiotensin Receptor Antagonist 50%
• Antiarrhythmic Agent 100%
• Calcium Channel Blocking Agent 50%
• Cardiac Dysrhythmia 50%
• Cardiac Glycoside 50%
• Cardiovascular Condition 50%
• Cardiovascular System 100%
• Clinician 50%
• Congestive Heart Failure 50%
• Diuretics 50%
• Endothelin Receptor Antagonist 50%
• Glucose 50%
• Hypertension 50%
• Internal Medicine 50%
• Loop Diuretic Agent 50%
• Perioperative Medicine 50%
• Phosphodiesterase V Inhibitor 50%
• Potassium Channel Opener 50%
• Potassium Sparing Diuretic Agent 50%
• Preoperative Evaluation 50%
• Quality Improvement 100%
• Renin Inhibitor 50%
• Sodium 50%
• Sodium Channel Blocker 50%
• Thiazide Diuretic Agent 50%

Keyphrases

• Class I Antiarrhythmic Drugs 50%
• Nitrodilator 50%
• Sodium-glucose 50%